Clinical Trial Update: Low Dose Ketamine and Acute Pain Crisis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating low-dose ketamine for acute pain crisis in sickle cell disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Rhode Island Hospital | Conditions: Sickle Cell Crisis | Phase 4 | Status: COMPLETED